查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1530919

代谢组学市场 - 2024-2034 年全球产业分析、规模、份额、成长、趋势和预测

Metabolomics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
出版日期: | 出版商: Transparency Market Research | 英文 237 Pages | 商品交期: 2-10个工作天内

价格

代谢组学市场 - 报告范围

TMR 关于全球代谢组学市场的报告研究了过去以及当前的成长趋势和机会，以获得 2024 年至 2034 年预测期内市场指标的宝贵见解。 -2034年，以2024年为基准年，2034年为预测年。报告也提供了2024年至2034年全球代谢组学市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解代谢组学市场。

市场概况
2023年市场价值 27亿美元
2034 年市场价值 95 亿美元
复合年增长率 12.3%

该报告深入探讨了全球代谢组学市场的竞争格局。全球代谢组学市场的主要参与者已被确定，并且每一位参与者都已根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球代谢组学市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概览

  • 介绍
  • 概述
  • 市场动态
  • 2020-2034 年全球市场分析与预测

第 5 章：关键见解

  • 产业最新进展
  • 专利分析
  • 主要地区/国家静脉支架的监管环境
  • 重要产业活动（产品核准、合作伙伴关係和协作）
  • COVID-19 大流行的影响

第 6 章：全球市场分析与预测：依产品与服务类型

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按产品和服务类型分類的市场价值预测
    • 仪器仪表
      • 分离工具
        • 高效液相层析法
        • 气相层析法
        • 超高效液相层析
        • 毛细管电泳
      • 检测工具
        • 质谱分析
        • 核磁共振波谱
        • 基于表面的品质分析
    • 生物资讯学工具和服务
      • 生物资讯服务
      • 生物资讯工具和资料库
  • 按产品和服务类型分類的市场吸引力

第 7 章：全球市场分析与预测：按应用分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年按应用分類的市场价值预测
    • 生物标记发现
    • 药物发现
    • 毒理学测试
    • 营养基因体学
    • 个人化医疗
    • 其他的
  • 按应用分類的市场吸引力

第 8 章：全球市场分析与预测：依指标分类

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年市场价值预测（依指标）
    • 肿瘤疾病
    • 心血管疾病
    • 神经系统疾病
    • 代谢紊乱
    • 其他的
  • 按指标分類的市场吸引力

第 9 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 2020-2034 年最终用户市场价值预测
    • 学术及研究机构
    • 製药和生物技术公司
    • 合约研究组织
  • 最终用户的市场吸引力

第 10 章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 按国家/地区分類的市场吸引力

第 11 章：北美市场分析与预测

  • 我们
  • 加拿大

第 12 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区

第 13 章：亚太市场分析与预测

  • 中国
  • 日本
  • 印度
  • 澳洲和纽西兰
  • 亚太地区其他地区

第 14 章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区

第 15 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第16章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 公司简介
    • Waters Corporation
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Bruker Corporation
    • PerkinElmer
    • Merck KGaA
    • Metabolon, Inc.
    • Afekta Technologies Ltd.
    • Shimadzu Corporation
Product Code: TMRGL903

Metabolomics Market - Scope of Report

TMR's report on the global metabolomics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global metabolomics market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global metabolomics market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the metabolomics market.

Market Snapshot
Market Value in 2023US$ 2.7 Bn
Market Value in 2034US$ 9.5 Bn
CAGR12.3%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global metabolomics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global metabolomics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global metabolomics market.

The report delves into the competitive landscape of the global metabolomics market. Key players operating in the global metabolomics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global metabolomics market profiled in this report.

Key Questions Answered in Global metabolomics Market Report:

  • What is the sales/revenue generated by metabolomics across all regions during the forecast period?
  • What are the opportunities in the global metabolomics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Metabolomics Market - Research Objectives and Research Approach

The comprehensive report on the global metabolomics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global metabolomics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global metabolomics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Metabolomics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Metabolomics Market Analysis and Forecasts, 2020-2034
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Recent Advancements in Metabolomics Industry
  • 5.2. Patent Analysis
  • 5.3. Regulatory Landscape for Venous Stents in Key Regions / Countries
  • 5.4. Key Industry Events (Product Approvals, Partnerships, and Collaborations)
  • 5.5. Impact of COVID-19 Pandemic

6. Global Metabolomics Market Analysis and Forecasts, By Product and Service Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product and Service Type, 2020-2034
    • 6.3.1. Metabolomics Instruments
      • 6.3.1.1. Separation Tools
        • 6.3.1.1.1. High Performance Liquid Chromatography
        • 6.3.1.1.2. Gas Chromatography
        • 6.3.1.1.3. Ultra Performance Liquid Chromatography
        • 6.3.1.1.4. Capillary Electrophoresis
      • 6.3.1.2. Detection Tools
        • 6.3.1.2.1. Mass Spectrometry
        • 6.3.1.2.2. Nuclear Magnetic Resonance Spectroscopy
        • 6.3.1.2.3. Surface-based Mass Analysis
    • 6.3.2. Bioinformatics Tools and Services
      • 6.3.2.1. Bioinformatics Services
      • 6.3.2.2. Bioinformatics Tools and Databases
  • 6.4. Market Attractiveness By Product and Service Type

7. Global Metabolomics Market Analysis and Forecasts, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Application, 2020-2034
    • 7.3.1. Biomarker Discovery
    • 7.3.2. Drug Discovery
    • 7.3.3. Toxicology Testing
    • 7.3.4. Nutrigenomics
    • 7.3.5. Personalized Medicine
    • 7.3.6. Others
  • 7.4. Market Attractiveness By Application

8. Global Metabolomics Market Analysis and Forecasts, By Indication

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Indication, 2020-2034
    • 8.3.1. Oncological Disorders
    • 8.3.2. Cardiovascular Disorders
    • 8.3.3. Neurological Disorders
    • 8.3.4. Metabolic Disorders
    • 8.3.5. Others
  • 8.4. Market Attractiveness By Indication

9. Global Metabolomics Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2020-2034
    • 9.3.1. Academic and Research Institutes
    • 9.3.2. Pharmaceutical and Biotechnology Companies
    • 9.3.3. Contract Research Organizations
  • 9.4. Market Attractiveness By End-user

10. Global Metabolomics Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Metabolomics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Product and Service Type, 2020-2034
    • 11.2.1. Metabolomics Instruments
      • 11.2.1.1. Separation Tools
        • 11.2.1.1.1. High Performance Liquid Chromatography
        • 11.2.1.1.2. Gas Chromatography
        • 11.2.1.1.3. Ultra Performance Liquid Chromatography
        • 11.2.1.1.4. Capillary Electrophoresis
      • 11.2.1.2. Detection Tools
        • 11.2.1.2.1. Mass Spectrometry
        • 11.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
        • 11.2.1.2.3. Surface-based Mass Analysis
    • 11.2.2. Bioinformatics Tools and Services
      • 11.2.2.1. Bioinformatics Services
      • 11.2.2.2. Bioinformatics Tools and Databases
  • 11.3. Market Value Forecast By Application, 2020-2034
    • 11.3.1. Biomarker Discovery
    • 11.3.2. Drug Discovery
    • 11.3.3. Toxicology Testing
    • 11.3.4. Nutrigenomics
    • 11.3.5. Personalized Medicine
    • 11.3.6. Others
  • 11.4. Market Value Forecast By Indication, 2020-2034
    • 11.4.1. Oncological Disorders
    • 11.4.2. Cardiovascular Disorders
    • 11.4.3. Neurological Disorders
    • 11.4.4. Metabolic Disorders
    • 11.4.5. Others
  • 11.5. Market Value Forecast By End-user, 2020-2034
    • 11.5.1. Academic and Research Institutes
    • 11.5.2. Pharmaceutical and Biotechnology Companies
    • 11.5.3. Contract Research Organizations
  • 11.6. Market Value Forecast By Country, 2020-2034
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product and Service Type
    • 11.7.2. By Application
    • 11.7.3. By Indication
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Metabolomics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product and Service Type, 2020-2034
    • 12.2.1. Metabolomics Instruments
      • 12.2.1.1. Separation Tools
        • 12.2.1.1.1. High Performance Liquid Chromatography
        • 12.2.1.1.2. Gas Chromatography
        • 12.2.1.1.3. Ultra Performance Liquid Chromatography
        • 12.2.1.1.4. Capillary Electrophoresis
      • 12.2.1.2. Detection Tools
        • 12.2.1.2.1. Mass Spectrometry
        • 12.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
        • 12.2.1.2.3. Surface-based Mass Analysis
    • 12.2.2. Bioinformatics Tools and Services
      • 12.2.2.1. Bioinformatics Services
      • 12.2.2.2. Bioinformatics Tools and Databases
  • 12.3. Market Value Forecast By Application, 2020-2034
    • 12.3.1. Biomarker Discovery
    • 12.3.2. Drug Discovery
    • 12.3.3. Toxicology Testing
    • 12.3.4. Nutrigenomics
    • 12.3.5. Personalized Medicine
    • 12.3.6. Others
  • 12.4. Market Value Forecast By Indication, 2020-2034
    • 12.4.1. Oncological Disorders
    • 12.4.2. Cardiovascular Disorders
    • 12.4.3. Neurological Disorders
    • 12.4.4. Metabolic Disorders
    • 12.4.5. Others
  • 12.5. Market Value Forecast By End-user, 2020-2034
    • 12.5.1. Academic and Research Institutes
    • 12.5.2. Pharmaceutical and Biotechnology Companies
    • 12.5.3. Contract Research Organizations
  • 12.6. Market Value Forecast By Country / Sub-region, 2020-2034
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product and Service Type
    • 12.7.2. By Application
    • 12.7.3. By Indication
    • 12.7.4. By End-user
    • 12.7.5. By Country / Sub-region

13. Asia Pacific Metabolomics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product and Service Type, 2020-2034
    • 13.2.1. Metabolomics Instruments
      • 13.2.1.1. Separation Tools
        • 13.2.1.1.1. High Performance Liquid Chromatography
        • 13.2.1.1.2. Gas Chromatography
        • 13.2.1.1.3. Ultra Performance Liquid Chromatography
        • 13.2.1.1.4. Capillary Electrophoresis
      • 13.2.1.2. Detection Tools
        • 13.2.1.2.1. Mass Spectrometry
        • 13.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
        • 13.2.1.2.3. Surface-based Mass Analysis
    • 13.2.2. Bioinformatics Tools and Services
      • 13.2.2.1. Bioinformatics Services
      • 13.2.2.2. Bioinformatics Tools and Databases
  • 13.3. Market Value Forecast By Application, 2020-2034
    • 13.3.1. Biomarker Discovery
    • 13.3.2. Drug Discovery
    • 13.3.3. Toxicology Testing
    • 13.3.4. Nutrigenomics
    • 13.3.5. Personalized Medicine
    • 13.3.6. Others
  • 13.4. Market Value Forecast By Indication, 2020-2034
    • 13.4.1. Oncological Disorders
    • 13.4.2. Cardiovascular Disorders
    • 13.4.3. Neurological Disorders
    • 13.4.4. Metabolic Disorders
    • 13.4.5. Others
  • 13.5. Market Value Forecast By End-user, 2020-2034
    • 13.5.1. Academic and Research Institutes
    • 13.5.2. Pharmaceutical and Biotechnology Companies
    • 13.5.3. Contract Research Organizations
  • 13.6. Market Value Forecast By Country / Sub-region, 2020-2034
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product and Service Type
    • 13.7.2. By Application
    • 13.7.3. By Indication
    • 13.7.4. By End-user
    • 13.7.5. By Country / Sub-region

14. Latin America Metabolomics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product and Service Type, 2020-2034
    • 14.2.1. Metabolomics Instruments
      • 14.2.1.1. Separation Tools
        • 14.2.1.1.1. High Performance Liquid Chromatography
        • 14.2.1.1.2. Gas Chromatography
        • 14.2.1.1.3. Ultra Performance Liquid Chromatography
        • 14.2.1.1.4. Capillary Electrophoresis
      • 14.2.1.2. Detection Tools
        • 14.2.1.2.1. Mass Spectrometry
        • 14.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
        • 14.2.1.2.3. Surface-based Mass Analysis
    • 14.2.2. Bioinformatics Tools and Services
      • 14.2.2.1. Bioinformatics Services
      • 14.2.2.2. Bioinformatics Tools and Databases
  • 14.3. Market Value Forecast By Application, 2020-2034
    • 14.3.1. Biomarker Discovery
    • 14.3.2. Drug Discovery
    • 14.3.3. Toxicology Testing
    • 14.3.4. Nutrigenomics
    • 14.3.5. Personalized Medicine
    • 14.3.6. Others
  • 14.4. Market Value Forecast By Indication, 2020-2034
    • 14.4.1. Oncological Disorders
    • 14.4.2. Cardiovascular Disorders
    • 14.4.3. Neurological Disorders
    • 14.4.4. Metabolic Disorders
    • 14.4.5. Others
  • 14.5. Market Value Forecast By End-user, 2020-2034
    • 14.5.1. Academic and Research Institutes
    • 14.5.2. Pharmaceutical and Biotechnology Companies
    • 14.5.3. Contract Research Organizations
  • 14.6. Market Value Forecast By Country / Sub-region, 2020-2034
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product and Service Type
    • 14.7.2. By Application
    • 14.7.3. By Indication
    • 14.7.4. By End-user
    • 14.7.5. By Country / Sub-region

15. Middle East & Africa Metabolomics Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product and Service Type, 2020-2034
    • 15.2.1. Metabolomics Instruments
      • 15.2.1.1. Separation Tools
        • 15.2.1.1.1. High Performance Liquid Chromatography
        • 15.2.1.1.2. Gas Chromatography
        • 15.2.1.1.3. Ultra Performance Liquid Chromatography
        • 15.2.1.1.4. Capillary Electrophoresis
      • 15.2.1.2. Detection Tools
        • 15.2.1.2.1. Mass Spectrometry
        • 15.2.1.2.2. Nuclear Magnetic Resonance Spectroscopy
        • 15.2.1.2.3. Surface-based Mass Analysis
    • 15.2.2. Bioinformatics Tools and Services
      • 15.2.2.1. Bioinformatics Services
      • 15.2.2.2. Bioinformatics Tools and Databases
  • 15.3. Market Value Forecast By Application, 2020-2034
    • 15.3.1. Biomarker Discovery
    • 15.3.2. Drug Discovery
    • 15.3.3. Toxicology Testing
    • 15.3.4. Nutrigenomics
    • 15.3.5. Personalized Medicine
    • 15.3.6. Others
  • 15.4. Market Value Forecast By Indication, 2020-2034
    • 15.4.1. Oncological Disorders
    • 15.4.2. Cardiovascular Disorders
    • 15.4.3. Neurological Disorders
    • 15.4.4. Metabolic Disorders
    • 15.4.5. Others
  • 15.5. Market Value Forecast By End-user, 2020-2034
    • 15.5.1. Academic and Research Institutes
    • 15.5.2. Pharmaceutical and Biotechnology Companies
    • 15.5.3. Contract Research Organizations
  • 15.6. Market Value Forecast By Country / Sub-region, 2020-2034
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product and Service Type
    • 15.7.2. By Application
    • 15.7.3. By Indication
    • 15.7.4. By End-user
    • 15.7.5. By Country / Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Company Profiles
    • 16.2.1. Waters Corporation
      • 16.2.1.1. Company Overview
      • 16.2.1.2. Financial Overview
      • 16.2.1.3. Product Portfolio
      • 16.2.1.4. Business Strategies
      • 16.2.1.5. Recent Developments
    • 16.2.2. Agilent Technologies, Inc.
      • 16.2.2.1. Company Overview
      • 16.2.2.2. Financial Overview
      • 16.2.2.3. Product Portfolio
      • 16.2.2.4. Business Strategies
      • 16.2.2.5. Recent Developments
    • 16.2.3. Thermo Fisher Scientific Inc.
      • 16.2.3.1. Company Overview
      • 16.2.3.2. Financial Overview
      • 16.2.3.3. Product Portfolio
      • 16.2.3.4. Business Strategies
      • 16.2.3.5. Recent Developments
    • 16.2.4. Danaher Corporation
      • 16.2.4.1. Company Overview
      • 16.2.4.2. Financial Overview
      • 16.2.4.3. Product Portfolio
      • 16.2.4.4. Business Strategies
      • 16.2.4.5. Recent Developments
    • 16.2.5. Bruker Corporation
      • 16.2.5.1. Company Overview
      • 16.2.5.2. Financial Overview
      • 16.2.5.3. Product Portfolio
      • 16.2.5.4. Business Strategies
      • 16.2.5.5. Recent Developments
    • 16.2.6. PerkinElmer
      • 16.2.6.1. Company Overview
      • 16.2.6.2. Financial Overview
      • 16.2.6.3. Product Portfolio
      • 16.2.6.4. Business Strategies
      • 16.2.6.5. Recent Developments
    • 16.2.7. Merck KGaA
      • 16.2.7.1. Company Overview
      • 16.2.7.2. Financial Overview
      • 16.2.7.3. Product Portfolio
      • 16.2.7.4. Business Strategies
      • 16.2.7.5. Recent Developments
    • 16.2.8. Metabolon, Inc.
      • 16.2.8.1. Company Overview
      • 16.2.8.2. Financial Overview
      • 16.2.8.3. Product Portfolio
      • 16.2.8.4. Business Strategies
      • 16.2.8.5. Recent Developments
    • 16.2.9. Afekta Technologies Ltd.
      • 16.2.9.1. Company Overview
      • 16.2.9.2. Financial Overview
      • 16.2.9.3. Product Portfolio
      • 16.2.9.4. Business Strategies
      • 16.2.9.5. Recent Developments
    • 16.2.10. Shimadzu Corporation
      • 16.2.10.1. Company Overview
      • 16.2.10.2. Financial Overview
      • 16.2.10.3. Product Portfolio
      • 16.2.10.4. Business Strategies
      • 16.2.10.5. Recent Developments

List of Tables

  • Table 01: Global Metabolomics Market Value (US$ Mn) Forecast, by Product and Service Type, 2020-2034
  • Table 02: Global Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instrument, 2020-2034
  • Table 03: Global Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
  • Table 04: Global Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 05: Global Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 06: Global Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 07: Global Metabolomics Market Value (US$ Mn) Forecast, by Region, 2020-2034
  • Table 08: North America Metabolomics Market Value (US$ Mn) Forecast, by Country, 2020-2034
  • Table 09: North America Metabolomics Market Value (US$ Mn) Forecast, by Product and Service Type, 2020-2034
  • Table 10: North America Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instrument, 2020-2034
  • Table 11: North America Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
  • Table 12: North America Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 13: North America Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 14: North America Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 15: Europe Metabolomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 16: Europe Metabolomics Market Value (US$ Mn) Forecast, by Product and Service Type, 2020-2034
  • Table 17: Europe Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instruments, 2020-2034
  • Table 18: Europe Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
  • Table 19: Europe Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 20: Europe Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 21: Europe Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 22: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 23: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Product and Service Type, 2020-2034
  • Table 24: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instruments, 2020-2034
  • Table 25: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
  • Table 26: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 27: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 28: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 29: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 30: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Product and Service Type, 2020-2034
  • Table 31: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instruments, 2020-2034
  • Table 32: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
  • Table 33: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 34: Latin America Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 35: Latin America Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034
  • Table 36: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
  • Table 37: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Product Type, 2020-2034
  • Table 38: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Metabolomic Instruments, 2020-2034
  • Table 39: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Bioinformatics Tools and Services, 2020-2034
  • Table 40: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Application, 2020-2034
  • Table 41: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by Indication, 2020-2034
  • Table 42: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

  • Figure 01: Global Metabolomics Market Value (US$ Mn) Forecast, 2020-2034
  • Figure 02: Global Metabolomics Market Value Share, by Product and Service Type, 2023
  • Figure 03: Global Metabolomics Market Value Share, by Application, 2023
  • Figure 04: Global Metabolomics Market Value Share, by Indication, 2023
  • Figure 05: Global Metabolomics Market Value Share, by End-user, 2023
  • Figure 06: Global Metabolomics Market Value Share, by Region, 2023
  • Figure 07: Global Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
  • Figure 08: Global Metabolomics Market Share Analysis, by Product and Service Type, 2023
  • Figure 09: Global Metabolomics Market Share Analysis, by Product and Service Type, 2034
  • Figure 10: Global Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
  • Figure 11: Global Metabolomics Market Value (US$ Mn), by Metabolomic Instruments, 2020-2034
  • Figure 12: Global Metabolomics Market Value Share Analysis, by Metabolomic Instruments, 2023 and 2034
  • Figure 13: Global Metabolomics Market Value (US$ Mn), by Bioinformatics Tools and Services, 2020-2034
  • Figure 14: Global Metabolomics Market Value Share Analysis, by Bioinformatics Tools and Services, 2023 and 2034
  • Figure 15: Global Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 16: Global Metabolomics Market Share Analysis, by Application, 2023
  • Figure 17: Global Metabolomics Market Share Analysis, by Application, 2034
  • Figure 18: Global Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 19: Global Metabolomics Market Value (US$ Mn), by Biomarker Discovery, 2020-2034
  • Figure 20: Global Metabolomics Market Value Share Analysis, by Biomarker Discovery, 2023 and 2034
  • Figure 21: Global Metabolomics Market Value (US$ Mn), by Drug Discovery, 2020-2034
  • Figure 22: Global Metabolomics Market Value Share Analysis, by Drug Discovery, 2023 and 2034
  • Figure 23: Global Metabolomics Market Value (US$ Mn), by Toxicology Testing, 2020-2034
  • Figure 24: Global Metabolomics Market Value Share Analysis, by Toxicology Testing, 2023 and 2034
  • Figure 25: Global Metabolomics Market Value (US$ Mn), by Nutrigenomics, 2020-2034
  • Figure 26: Global Metabolomics Market Value Share Analysis, by Nutrigenomics, 2023 and 2034
  • Figure 27: Global Metabolomics Market Value (US$ Mn), by Personalized Medicine, 2020-2034
  • Figure 28: Global Metabolomics Market Value Share Analysis, by Personalized Medicine, 2023 and 2034
  • Figure 29: Global Metabolomics Market Value (US$ Mn), by Others, 2020-2034
  • Figure 30: Global Metabolomics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 31: Global Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
  • Figure 32: Global Metabolomics Market Share Analysis, by Indication, 2023
  • Figure 33: Global Metabolomics Market Share Analysis, by Indication, 2034
  • Figure 34: Global Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 35: Global Metabolomics Market Value (US$ Mn), by Oncological Disorders, 2020-2034
  • Figure 36: Global Metabolomics Market Value Share Analysis, by Oncological Disorders, 2023 and 2034
  • Figure 37: Global Metabolomics Market Value (US$ Mn), by Cardiovascular Disorders, 2020-2034
  • Figure 38: Global Metabolomics Market Value Share Analysis, by Cardiovascular Disorders, 2023 and 2034
  • Figure 39: Global Metabolomics Market Value (US$ Mn), by Neurological Disorders, 2020-2034
  • Figure 40: Global Metabolomics Market Value Share Analysis, by Neurological Disorders, 2023 and 2034
  • Figure 41: Global Metabolomics Market Value (US$ Mn), by Metabolic Disorders, 2020-2034
  • Figure 42: Global Metabolomics Market Value Share Analysis, by Metabolic Disorders, 2023 and 2034
  • Figure 43: Global Metabolomics Market Value (US$ Mn), by Others, 2020-2034
  • Figure 44: Global Metabolomics Market Value Share Analysis, by Others, 2023 and 2034
  • Figure 45: Global Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 46: Global Metabolomics Market Share Analysis, by End-user, 2023
  • Figure 47: Global Metabolomics Market Share Analysis, by End-user, 2034
  • Figure 48: Global Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 49: Global Metabolomics Market Value (US$ Mn), by Academic and Research Institutes, 2020-2034
  • Figure 50: Global Metabolomics Market Value Share Analysis, by Academic and Research Institutes, 2023 and 2034
  • Figure 51: Global Metabolomics Market Value (US$ Mn), by Pharmaceutical and Biotechnology Companies, 2020-2034
  • Figure 52: Global Metabolomics Market Value Share Analysis, by Pharmaceutical and Biotechnology Companies, 2023 and 2034
  • Figure 53: Global Metabolomics Market Value (US$ Mn), by Contract Research Organizations, 2020-2034
  • Figure 54: Global Metabolomics Market Value Share Analysis, by Contract Research Organizations, 2023 and 2034
  • Figure 55: Global Metabolomics Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 56: Global Metabolomics Market Share Analysis, by Region, 2023
  • Figure 57: Global Metabolomics Market Share Analysis, by Region, 2034
  • Figure 58: Global Metabolomics Market Attractiveness Analysis, by Region, 2023-2034
  • Figure 59: North America Metabolomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 60: North America Metabolomics Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 61: North America Metabolomics Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 62: North America Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
  • Figure 63: North America Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
  • Figure 64: North America Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 65: North America Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 66: North America Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
  • Figure 67: North America Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 68: North America Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 69: North America Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 70: Europe Metabolomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 71: Europe Metabolomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 72: Europe Metabolomics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 73: Europe Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
  • Figure 74: Europe Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
  • Figure 75: Europe Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 76: Europe Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
  • Figure 77: Europe Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 78: Europe Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 79: Europe Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 80: Europe Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 81: Asia Pacific Metabolomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 82: Asia Pacific Metabolomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 83: Asia Pacific Metabolomics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 84: Asia Pacific Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
  • Figure 85: Asia Pacific Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
  • Figure 86: Asia Pacific Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 87: Asia Pacific Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
  • Figure 88: Asia Pacific Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 89: Asia Pacific Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 90: Asia Pacific Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 91: Asia Pacific Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 92: Latin America Metabolomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 93: Latin America Metabolomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 94: Latin America Metabolomics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 95: Latin America Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
  • Figure 96: Latin America Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
  • Figure 97: Latin America Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 98: Latin America Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 99: Latin America Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
  • Figure 100: Latin America Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 101: Latin America Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 102: Latin America Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034
  • Figure 103: Middle East & Africa Metabolomics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2020-2034
  • Figure 104: Middle East & Africa Metabolomics Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 105: Middle East & Africa Metabolomics Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 106: Middle East & Africa Metabolomics Market Value (US$ Mn) Share Analysis, by Product and Service Type, 2023 and 2034
  • Figure 107: Middle East & Africa Metabolomics Market Attractiveness Analysis, by Product and Service Type, 2024-2034
  • Figure 108: Middle East & Africa Metabolomics Market Value (US$ Mn) Share Analysis, by Application, 2023 and 2034
  • Figure 109: Middle East & Africa Metabolomics Market Attractiveness Analysis, by Application, 2024-2034
  • Figure 110: Middle East & Africa Metabolomics Market Value (US$ Mn) Share Analysis, by Indication, 2023 and 2034
  • Figure 111: Middle East & Africa Metabolomics Market Attractiveness Analysis, by Indication, 2024-2034
  • Figure 112: Middle East & Africa Metabolomics Market Value (US$ Mn) Share Analysis, by End-user, 2023 and 2034
  • Figure 113: Middle East & Africa Metabolomics Market Attractiveness Analysis, by End-user, 2024-2034